Cytek Investor Presentation Deck

Strategic Rationale: Cytek to Acquire Amnis & Guava Lines O High synergy to core business Cell Imaging, Al Bioinformatics, and Capillary Fluidics CYTEK TRANSCEND THE CONVENTIONAL Rapid revenue expansion from larger global footprint ull Cytek's Cell Sorting with Amnis imaging technology COT Synergies in go-to-market and service functions. Increase in operating leverage New markets and research areas for Cytek machines. =$ Substantial accretion to Cytek's revenue

View entire presentation